Lv31
236 积分 2026-07-16 加入
Discovery of a covalent FGFR2-selective inhibitor overcoming clinically-acquired resistance mutations
2个月前
已完结
Discovery of Potential Acetohydroxyacid Synthase Covalent Inhibitors with Integrated Virtual Screening Approach
2个月前
已完结
ff19SB: Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum Mechanics Energy Surfaces in Solution
2个月前
已完结
Identification of Noncovalent Small-Molecules from Virtual Screening Toward the Development of Potential KRAS Inhibitors
2个月前
已完结
Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic Core
2个月前
已完结
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
2个月前
已完结
gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS
2个月前
已完结
Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use
3个月前
已完结
Reaction Mechanism and Catalytic Determinants of a Highly Active De Novo Metalloesterase
3个月前
已完结
Distinctive Formation of a DNA–Protein Cross-Link during the Repair of DNA Oxidative Damage: Insights into Human Disease from MD Simulations and QM/MM Calculations
3个月前
已完结
皖公网安备34019202002308
